AML develops with a latency of weeks in mice transplanted with bone marrow transduced with vectors to express MLL1-oncoproteins or to overexpress HoxA10, suggesting leukemogenesis requires additional mutations (4, 11, 12, 13). Here, KMT2A is linked to acute myeloid leukemia.